ENZB — Enzo Biochem Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Enzo Biochem, fiscal year end - July 31st, USD millions except per share, conversion factor applied.

	2020 July 31st	2021 July 31st	R2022 July 31st	2023 July 31st	2024 July 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	47.9	43.5	21.6	82.4	52.4
Net Total Accounts Receivable
Net Total Receivables	9.14	10.2	4.76	4.81	3.99
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	68.8	70.6	42.8	98.5	70
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	34.4	33.6	16	16.7	15.2
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	113	114	75.6	122	85.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	32.8	26.1	13	40	24.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	54.2	45.1	21.1	43.4	29.7
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	58.4	68.6	54.5	78.5	56.1
Total Liabilities & Shareholders' Equity	113	114	75.6	122	85.8
Total Common Shares Outstanding